Carl A. Gregory

Institute for Regenerative Medicine at Scott & White Hospital, Texas A&M Health Science Center

Affiliated withTexas A&M Health Science Center

Research Area

Biography

Carl A. Gregory has not added Biography.
If you are Carl A. Gregory and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 17	2015

Other Publications

Article	Year
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. The Journal of biological chemistry\| PubMed ID: 12740383	2003
One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 13679583	2003
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 15120336	2004
An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Analytical biochemistry\| PubMed ID: 15136169	2004
Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. The Journal of biological chemistry\| PubMed ID: 15504735	2005
Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Experimental cell research\| PubMed ID: 15925588	2005
How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Annals of the New York Academy of Sciences\| PubMed ID: 15965110	2005
Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate. Science's STKE : signal transduction knowledge environment\| PubMed ID: 16046665	2005
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in... Stem cells (Dayton, Ohio)\| PubMed ID: 16293576	2006
Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs. Stem cells (Dayton, Ohio)\| PubMed ID: 16763199	2006
The promise of canonical Wnt signaling modulators in enhancing bone repair. Drug news & perspectives\| PubMed ID: 17160144	2006
More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow. Leukemia & lymphoma\| PubMed ID: 17917957	2007
Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. Tissue engineering. Part A\| PubMed ID: 18637760	2009
The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood\| PubMed ID: 18818395	2009
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs). BMC biotechnology\| PubMed ID: 18823563	2008
CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19690521	2009
Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20150512	2010
Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood\| PubMed ID: 21123822	2011
Assays of osteogenic differentiation by cultured human mesenchymal stem cells. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 21431522	2011
Potential of modulating Wnt signaling pathway toward the development of bone anabolic agent. Current molecular pharmacology\| PubMed ID: 21787289	2012
Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration. Science translational medicine\| PubMed ID: 22553253	2012
Bone regeneration with osteogenically enhanced mesenchymal stem cells and their extracellular matrix proteins. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research\| PubMed ID: 25130615	2015
MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 25548183	2015